Inventory / revenue moved 831 bp lower
Inventory / revenue changed -831 basis points from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Inventory / revenue changed -831 basis points from the comparable as-filed period.
Gross profit changed +25.8% from the comparable as-filed period.
Stock-based compensation changed +57.8% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Cost of revenue changed +23.4% from the comparable as-filed period.
Debt / revenue changed -3955 basis points from the comparable as-filed period.
Selling, general & administrative changed +19.5% from the comparable as-filed period.
Gross margin changed +50 basis points from the comparable as-filed period.
Net debt changed +107.2% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change. This reverses 3 consecutive comparable moves in the opposite direction.
Free-cash-flow margin changed +1120 basis points from the comparable as-filed period.
Operating cash-flow margin changed +1131 basis points from the comparable as-filed period.
Current liabilities changed +4.5% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Capital expenditure changed +28.0% from the comparable as-filed period.
Receivables / revenue changed -183 basis points from the comparable as-filed period.
SBC / revenue changed +54 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Noncurrent long-term debt changed +0.2% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Inventory changed +8.7% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
R&D / revenue changed -82 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Research & development changed +2.0% from the comparable as-filed period.
Capex / revenue changed +12 basis points from the comparable as-filed period.
Total assets changed +0.2% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Debt / assets changed -4 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Gross debt changed -0.2% from the comparable as-filed period. The change ranks at the 46th percentile of 13 prior comparable changes.
Free-cash-flow proxy changed +1236.1% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a low base.
Selling, general & administrative changed +27.2% from the comparable as-filed period.
Inventory / revenue changed -535 basis points from the comparable as-filed period.
Stock-based compensation changed +109.1% from the comparable as-filed period.
Debt / assets changed -360 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Cash / debt changed +3500 basis points from the comparable as-filed period.
Debt / revenue changed -3269 basis points from the comparable as-filed period.
Receivables / revenue changed +262 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Free-cash-flow margin changed +1641 basis points from the comparable as-filed period.
Operating cash-flow margin changed +1636 basis points from the comparable as-filed period.
Working capital / assets changed +221 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
SBC / revenue changed +111 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Inventory changed +9.9% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Cost of revenue changed +11.0% from the comparable as-filed period.
Capital expenditure changed +18.2% from the comparable as-filed period.
R&D / revenue changed -70 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Capex / revenue changed -5 basis points from the comparable as-filed period.
Current liabilities changed +3.4% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Research & development changed +1.0% from the comparable as-filed period.
Gross debt changed +0.1% from the comparable as-filed period. The change ranks at the 25th percentile of 12 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Noncurrent long-term debt changed -0.2% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.